Duvnjak Petar, Schulman Ariel A, Holtz Jamie N, Huang Jiaoti, Polascik Thomas J, Gupta Rajan T
Department of Radiology, Duke University Medical Center, DUMC Box 3808, Durham, NC 27710, USA; Department of Radiology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA.
Division of Urologic Surgery, Department of Surgery, Duke Prostate Center, Duke University Medical Center, DUMC Box 2804, Durham, NC 27710, USA.
Radiol Clin North Am. 2018 Mar;56(2):239-250. doi: 10.1016/j.rcl.2017.10.007. Epub 2017 Dec 11.
Meaningful changes to the approach of prostate cancer staging and management have been made over the past decade with increasing demand for high-quality multiparametric MR imaging (mpMRI) of the prostate. This article focuses on the evolving paradigm of prostate cancer staging, with emphasis on the role of mpMRI on staging and its integration into clinical decision making. Current prostate cancer staging systems are defined and mpMRI's role in the detection of non-organ-confined disease and how it has an impact on the selection of appropriate next steps are discussed. Several imaging pitfalls, limitations, and future directions of mpMRI also are discussed.
在过去十年中，随着对高质量前列腺多参数磁共振成像（mpMRI）的需求不断增加，前列腺癌分期和管理方法发生了有意义的变化。本文重点关注前列腺癌分期的不断演变的模式，强调mpMRI在分期中的作用及其在临床决策中的整合。定义了当前的前列腺癌分期系统，并讨论了mpMRI在检测非器官局限性疾病中的作用以及它如何影响适当后续步骤的选择。还讨论了mpMRI的一些成像陷阱、局限性和未来方向。
